These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease. Le Van Kim C; Mouro I; Brossard Y; Chavinié J; Cartron JP; Colin Y Br J Haematol; 1994 Sep; 88(1):193-5. PubMed ID: 7803243 [TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease. Spence WC; Maddalena A; Demers DB; Bick DP Obstet Gynecol; 1995 Feb; 85(2):296-8. PubMed ID: 7824249 [TBL] [Abstract][Full Text] [Related]
5. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease]. Misković B; Stipoljev F; Hadzisejdić I; Grahovac B Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells. Lighten AD; Overton TG; Sepulveda W; Warwick RM; Fisk NM; Bennett PR Am J Obstet Gynecol; 1995 Oct; 173(4):1182-5. PubMed ID: 7485316 [TBL] [Abstract][Full Text] [Related]
7. Early detection of RhD status in pregnancies at risk of hemolytic disease of the newborn. Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Racca A Clin Exp Med; 2002 Jul; 2(2):77-81. PubMed ID: 12141530 [TBL] [Abstract][Full Text] [Related]
8. [Rh system genotyping in amniotic fluid]. Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Martino W; Racca A Medicina (B Aires); 2001; 61(1):76-8. PubMed ID: 11265629 [TBL] [Abstract][Full Text] [Related]
9. RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype. Denomme GA; Akoury H; Sermer M; Kelton JG Prenat Diagn; 1999 May; 19(5):424-7. PubMed ID: 10360510 [TBL] [Abstract][Full Text] [Related]
13. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation. Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127 [TBL] [Abstract][Full Text] [Related]
14. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D. Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752 [TBL] [Abstract][Full Text] [Related]
15. Determination of fetal RHD type in plasma of RhD negative pregnant women. Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532 [TBL] [Abstract][Full Text] [Related]
17. Prenatal determination of fetal RhD type by DNA amplification. Bennett PR; Le Van Kim C; Colin Y; Warwick RM; Chérif-Zahar B; Fisk NM; Cartron JP N Engl J Med; 1993 Aug; 329(9):607-10. PubMed ID: 8341334 [TBL] [Abstract][Full Text] [Related]
18. Antenatal genotyping of the blood groups of the fetus. Avent ND Vox Sang; 1998; 74 Suppl 2():365-74. PubMed ID: 9704469 [TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of the RhD fetal blood type on amniotic fluid by polymerase chain reaction. Van Den Veyver IB; Subramanian SB; Hudson KM; Werch J; Moise KJ; Hughes MR Obstet Gynecol; 1996 Mar; 87(3):419-22. PubMed ID: 8598966 [TBL] [Abstract][Full Text] [Related]
20. [RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible]. Orzińska A; Engel K; Łakomy M; Smolarczyk-Wodzyńska J; Lipińska A; Pelc-Kłopotowska M; Brojer E Ginekol Pol; 2009 Oct; 80(10):786-90. PubMed ID: 19943546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]